共 50 条
New Generics for ADHD and Binge-Eating Disorder
被引:0
|作者:
Aschenbrenner, Diane S.
[1
,2
]
机构:
[1] Notre Dame Maryland Univ, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA
关键词:
D O I:
10.1097/01.NAJ.0001004924.17699.55
中图分类号:
R47 [护理学];
学科分类号:
1011 ;
摘要:
Generic versions of the central nervous system stimulant lisdexamfetamine dimesylate (Vyvanse) capsules and chewable tablets are now approved to treat attention deficit-hyperactivity disorder in children ages six years and older and moderate to severe binge-eating disorder in adults.The Food and Drug Administration offers online content that can be used in patient education about generics.
引用
收藏
页码:19 / 19
页数:1
相关论文